Title  | Date  | Price |
|---|
Lundbeck IMS Company Profile
| Nov 2008 |
£510 |
Pfizer Inc.
| Nov 2008 |
£300 |
UCB: Performance, Products, Pipeline and Potential
| Nov 2008 |
£595 |
King Pharmaceuticals IMS Company Profile
| Oct 2008 |
£510 |
Biogen Idec IMS Company Profile
| Oct 2008 |
£510 |
Schering-Plough
Pipeline ,Products ,Performance ,Potential
| Aug 2008 |
£595 |
Byetta Case Study
Using Medical Education as a Springboard for Product Launch
| Aug 2008 |
£2,640 |
Novartis
Pipeline ,Products ,Performance ,Potential
| Aug 2008 |
£595 |
Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment Paradigm
| Aug 2008 |
£3,005 |
Shire
| Jul 2008 |
£510 |
Eisai
| Jul 2008 |
£510 |
Astellas
| Jul 2008 |
£510 |
Pfizer
| Jul 2008 |
£510 |
Exubera Case Study
Misjudging The Market
| Jul 2008 |
£1,500 |
Solvay
Pipeline Products Performance Potential
| Jun 2008 |
£595 |
Mylan IMS Company Profile
| Jun 2008 |
£510 |
AstraZeneca:
Pipeline Products Performance Potential
Pharmaceuticals, Company Profile and Healthcare
| Jun 2008 |
£595 |
Novo Nordisk:
Pipeline Products Performance Potential
| May 2008 |
£595 |
Alcon:
Pipeline Products Performance Potential
| May 2008 |
£595 |
Otsuka
Pipeline, Products, Performance, Potential
| Apr 2008 |
£595 |
Baxter IMS Company Profile
| Apr 2008 |
£510 |
Biogen Idec, Inc.
SWOT Analysis
| Apr 2008 |
£75 |
Shionogi:
Pipeline Products Performance Potential
| Mar 2008 |
£595 |
Allergan: Pipeline , Products , Performance , Potential
| Feb 2008 |
£595 |
Astellas: Pipeline , Products , Performance , Potential
| Feb 2008 |
£595 |
Eisai
Pipeline, Products, Performance, Potential
| Jan 2008 |
£595 |
Mitsubishi Tanabe Pharma
Pipeline, Products, Performance, Potential
| Jan 2008 |
£595 |
Abbott Laboratories
PharmaVitae Profile
| Dec 2007 |
£3,425 |
AstraZeneca Plc (Incl. MedImmune Inc.)
PharmaVitae Profile
| Dec 2007 |
£3,425 |
Biogen Idec Inc.
PharmaVitae Profile
| Dec 2007 |
£3,425 |
Bristol-Myers Squibb Co.
PharmaVitae Profile
| Dec 2007 |
£3,425 |
Eisai Co., Ltd
PharmaVitae Profile
| Dec 2007 |
£3,425 |
Allergan Inc.
PharmaVitae Profile
| Dec 2007 |
£3,425 |
Abbott Laboratories Strategic Analysis Profile
| Dec 2007 |
£490 |
Alcon Inc. Strategic Analysis Profile
| Dec 2007 |
£490 |
MedImmune Inc.: PharmaVitae Profile
| Nov 2007 |
£3,425 |
Chugai: Pharmavitae Profile 2007
| Oct 2007 |
£3,425 |
Roche: Pharmavitae Profile
| Oct 2007 |
£3,425 |
Watson
Pharmavitae Generics Profile
| Sep 2007 |
£2,280 |
Sanofi-aventis: Pipeline, Products, Performance, Potential
| Sep 2007 |
£595 |
Johnson&Johnson IMS Company Profile
| Jul 2007 |
£510 |
Global - Services - E-health
| Jun 2007 |
£24 |
GlaxoSmithKline: PharmaVitae Profile
| Jan 2007 |
£3,425 |
Serono IMS Company Profile
| Dec 2006 |
£510 |
Johnson & Johnson Inc
| Feb 2006 |
£195 |
Amgen
Profile, Patents and Pipeline
| Aug 2005 |
£300 |
first
previous
